Keith A. Meister, a director and ten percent owner of GeneDx Holdings Corp. (NASDAQ:WGS), along with Corvex Management LP, purchased $13,765,344 worth of the company’s Class A Common Stock.
Transactions occurred between May 13-15, 2026, with prices ranging from $38.28 to $39.92 per share.
The stock currently trades at $40.75, down sharply from its 52-week high of $170.87. The company has declined 68% over the past six months.
On May 13, Corvex bought 94,074 shares at an average $38.82, and another 70,926 shares at $39.45.
On May 14, 88,107 shares were purchased at $39.08, and 51,893 shares at $39.92.
On May 15, 27,408 shares at $38.28, and 18,865 shares at $39.83 were acquired.
Corvex-managed funds hold 4,784,570 shares. Meister has indirect control over these shares.
CMLS Holdings LLC holds 333,144 shares, with Meister sharing voting and investment power. He also directly owns 20,129 shares.
GeneDx’s Q1 earnings missed estimates: EPS -$0.28 vs -$0.01 expected, revenue $102.3M vs $112.45M expected. Canaccord and BTIG lowered price targets but maintained Buy ratings.
